THOMAS R GRAZIANO
Allopathic & Osteopathic Physicians|Internal Medicine CENTREVILLE, VA NPI 1679547764
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine VA ABBVIE INC. All categories
General Payments — all program years on this page
$2,264.49
- Category: General Payments
- Program years: PY2018–2022
- Record count: 148
- As of (CMS publication): 2026-01-23
Latest program year (PY2022): $151.91 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2022) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $151.91 | 8 |
By paying entity
Latest program year (PY2022) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $41.13 | 2 |
| Janssen Pharmaceuticals, Inc | $22.56 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.32 | 1 |
| E.R. Squibb & Sons, L.L.C. | $19.64 | 1 |
| Novo Nordisk AS | $16.49 | 1 |
| Astellas Pharma US Inc | $15.17 | 1 |
| Esperion Therapeutics, Inc. | $14.60 | 1 |
By program year
Records — PY2022 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 886961553 | Janssen Pharmaceuticals, Inc | $22.56 | 04/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 887678907 | Boehringer Ingelheim Pharmaceuticals, Inc. | $22.32 | 02/08/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 892682119 | ABBVIE INC. | $18.19 | 01/20/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 892682121 | ABBVIE INC. | $22.94 | 01/27/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 899200659 | Novo Nordisk Inc | $16.49 | 03/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 932705165 | E.R. Squibb & Sons, L.L.C. | $19.64 | 03/08/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 940140475 | Astellas Pharma US Inc | $15.17 | 03/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 947256617 | Esperion Therapeutics, Inc. | $14.60 | 05/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.